HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center — Saint Louis Park, Minnesota

HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center is a clinical research site located in Saint Louis Park, Minnesota, United States 55426.

Crixeo Health Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center?

HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center conducted?

HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Is HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center accredited by Crixeo Health?

HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.